Bio-Rad Laboratories (BIO +1.1%) could be a tasty purchase due its low valuation and prudent...

|About: Bio-Rad Laboratories, Inc. (BIO)|By:, SA News Editor

Bio-Rad Laboratories (BIO +1.1%) could be a tasty purchase due its low valuation and prudent management, according to analysts. Chatter on the street sees the life-science equipment maker making a nice "bolt-on" acquisition for either Thermo Fisher (TMO +3.1%) or Life Technologies (LIFE -1.6%).